Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers

Sotera Health Company is rated BUY, leveraging a vertically integrated model and strong MOAT in global medical equipment sterilization. SHC benefits from high customer switching costs, multi-year contracts with major healthcare firms, and robust pricing power in mission critical services. Q2 2026 results exceeded expectations, prompting raised full-year guidance; SHC trades at a discount to peers on forward EV/EBITDA despite superior margins.

Seeking Alpha • Sep 18, 2026

Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha • Sep 9, 2026

Sotera Health Q2 Earnings Call Highlights

Sotera Health NASDAQ: SHC reported second-quarter 2026 results that included 8% constant-currency revenue growth, higher adjusted EBITDA margins and an increase to its full-year revenue and adjusted EBITDA outlook.

MarketBeat • Aug 7, 2026

Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript

Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 6, 2026

Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis (1) compared to Q2 2025 Q2 2026 net income of $54 million or $0.19 per diluted share, compared to net income of $8 million or $0.03 per diluted share in Q2 2025 Q2 2026 Adjusted EBITDA ( 1 ) increased 10.0%, or 8.7% on a constant currency basis Q2 2026 Adjusted EPS (1) of $0.26, an increase of 30% per diluted share Company raises both full-year 2026 net revenues growth out look to 5.25% - 6.75% and Adjusted EBITDA growth outlook to 5.75% - 7.25%, on a constant currency basis CLEVELAND, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and six- months ended June 30, 2026. “We delivered another strong quarter, with high-single-digit growth, reflecting focused execution across all three of our business units,” said Chief Executive Officer Alton Shader.

GlobeNewsWire • Aug 6, 2026

Sotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Aug 6, 2026

Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates

Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.2 per share a year ago.

Zacks Investment Research • Aug 6, 2026

Sotera Health Announces Second-Quarter 2026 Earnings Release Date

CLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2026 before the market opens on Thursday, August 6, 2026. Following the release, management will host a conference call at 9:00 a.m.

GlobeNewsWire • Jul 23, 2026

Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Seeking Alpha • Jun 8, 2026

Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Seeking Alpha • Jun 3, 2026